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EVALUATION OF TUMOR NECROSIS FACTOR ALPHA IN SLEEP-DEPRIVED MENOPAUSALINDUCED RATS AND THE IMPACT ON BONE HEALTH
Ellsworth, N., Curry III, D., DeLeon, CJ, Frisch, F.

CREAN COLLEGE OF HEALTH AND BEHAVIORAL SCIENCES, CHAPMAN UNIVERSITY

Osteoporosis is a metabolic bone disorder characterized by a loss of bone mass
and a deterioration of the tissue that can ultimately lead to compromised bone
strength and an increased risk of fractures. The disease can affect a wide range
of individuals of both sexes but is most prevalent among older women,
particularly Caucasians (Cosman et al., 2014). Post-menopausal women are
considerably more susceptible to the disease due to their significant decreased
levels of estrogen. Estrogen deficiency directly causes a notable decrease in
bone due to the role estrogen plays in osteoclast apoptosis. Without the ability
to regulate osteoclastic apoptosis, bone resorption goes unmediated and results
in a decrease in bone strength (Kameda et al., 1997). TNF Alpha (TNF ɑ) is a
proinflammatory cytokine that is directly involved in bone turnover by
inhibiting mature osteoblasts (Kotrych., 2016). Cytokines are proteins that are
able to interact and carry out integral functions between cells when released.
When the body is deficient in estrogen, it will produce rapid resorption of bone
caused by TNF ɑ and will result in lower bone density and strength. TNF ɑ
inhibits bone-forming cells, osteoblasts, from maturing and consequently no
more bone will form (Azuma et al., 2000). TNF ɑ has also been seen in recent
findings to promote the formation of bone breaking cells through
osteoclastogenesis (Osta, Benedetti, & Miosecc, 2014). When the body is in a
state of inflammation and TNF ɑ is being secreted in high amounts, the effects
on the bone can be detrimental due to the upregulation of the cells to tear down
the bone and the inhibition of the cells to rebuild causing an imbalance. This
current study evaluates the impact of chronic sleep deprivation and
Zolendronate on the of TNF ɑ of ovariectomized Wistar rats during a five-week
sleep deprivation period.

Thirty-two female, ovariectomized Wistar rats were randomly placed in Control
(C), Zolendronate (Z), Sleep Deprived (SD), and Sleep Deprived with
Zolendronate (SDZ) groups. The SD and SDZ groups underwent a five week
sleep deprivation protocol using a MMPM tank while the C and Z groups were
placed in control tanks. The C group was given an injection of 0.9% saline
solution and the Z and SDZ groups were administered a dose of 10% mL/g
Zolendronate. The experimental group rats were randomly placed into one of
three possible sleep schedules following a one week adaptation period. After the
five week sleep deprivation protocol, the rats were injected with ketamine and
humanely sacrificed. Blood was collected from each animal for use in the TNF
ɑ ELISA Assay.
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Figure 1: TNF ɑ concentration values
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Table 1: TNF ɑ concentration values with standard deviation
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It was expected that the concentration of TNF ɑ would be increased in the rats that
experienced the sleep deprivation and lower in those that were sleep deprived but
given the Zolendronate treatment. This was the outcome seen as the sleep deprivation
group had a mean of 25.557 pg/mL with a standard deviation of 2.563 pg/mL and the
sleep deprivation group treated with Zolendronate had a mean of 24.017 pg/mL with a
standard deviation of 2.171 pg/ mL. Although the difference is not great, this can be
attributed to length of the sleep deprivation condition being too short. With a longer
time frame, based on previous research, sleep deprived groups would have a
significantly larger concentration of the TNF ɑ. The Zolendronate groups results were
the opposite of what was expected. The rats treated with the bisphosphonate drug was
seen to have the greatest concentration of TNF ɑ whereas it was expected to have the
lowest concentration. TNF ɑ levels were significantly higher in the Zol group than
both the control and SD, and SDZ groups (p<0.01) In human patients, Zolendronate
has been seen to cause patients to have symptoms of transient fever for twenty-one
days after injection of the drug. Therefore, the cytokine levels would be in a large
concentration due to immune response accounting for this unexpected result. In
regards to the similar values of the SD, control, and SDZ groups, this can be attributed
to a possible immune system exhaustion of the animals. Based on these findings, more
research must be done in this field of study to determine if Zolendronate would
positively impact on bone health with patients who exhibit chronic sleep deprivation
and in a post-menopausal state.

Significant changes in TNF ɑ concentrations were not seen as a result of the sleep
deprivation or Zolendronate injection. One limitation of this study is the short time
frame of the sleep deprivation protocol and small sample size. Future studies regarding
sleep deprivation should address this issue and allow for a longer time frame along with
a larger sample size in order to explore the relationship further between sleep
deprivation and loss of estrogen. Since postmenopausal osteoporosis and sleep
deprivation is prevalent in executive women, future research will help to better
understand the factors that impact bone health among aging executive women and
possible avenues to prevent this from occurring.

